These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1970503)
41. Relative selectivity of different beta-adrenoceptor antagonists for human heart beta 1- and beta 2-receptor subtypes assayed by a radioligand binding technique. Golf S; Bjørnerheim R; Erichsen A; Hansson V Scand J Clin Lab Invest; 1987 Nov; 47(7):719-23. PubMed ID: 2891183 [TBL] [Abstract][Full Text] [Related]
42. Mode of action of (-)-pindolol on feline and human myocardium. Kaumann AJ; Lobnig BM Br J Pharmacol; 1986 Sep; 89(1):207-18. PubMed ID: 2879589 [TBL] [Abstract][Full Text] [Related]
43. Effects of autoantibodies against beta(1)-adrenoceptor in hepatitis virus myocarditis on action potential and L-type Ca(2+) currents. Liu K; Liao YH; Wang ZH; Li SL; Wang M; Zeng LL; Tang M World J Gastroenterol; 2004 Apr; 10(8):1171-5. PubMed ID: 15069720 [TBL] [Abstract][Full Text] [Related]
44. Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro. Hancock AA; Buckner SA; Ireland LM; Knepper SM; Kerwin JF J Recept Signal Transduct Res; 1995; 15(7-8):863-85. PubMed ID: 8673721 [TBL] [Abstract][Full Text] [Related]
45. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers. Pauwels PJ; Gommeren W; Van Lommen G; Janssen PA; Leysen JE Mol Pharmacol; 1988 Dec; 34(6):843-51. PubMed ID: 2462161 [TBL] [Abstract][Full Text] [Related]
46. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent. Miyagishi A; Nakahara H; Hara Y Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068 [TBL] [Abstract][Full Text] [Related]
48. Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium. Lowe MD; Lynham JA; Grace AA; Kaumann AJ Br J Pharmacol; 2002 Jan; 135(2):451-61. PubMed ID: 11815381 [TBL] [Abstract][Full Text] [Related]
49. Effects of pindolol on vascular smooth muscle. Clark BJ; Bertholet A Gen Pharmacol; 1983; 14(1):117-9. PubMed ID: 6826021 [TBL] [Abstract][Full Text] [Related]
50. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies. Stoschitzky K; Klein W; Stark G; Stark U; Zernig G; Graziadei I; Lindner W Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749 [TBL] [Abstract][Full Text] [Related]
51. Distribution of metoprolol enantiomers in a fatal overdose. Mozayani A; Singer P; Jones G J Anal Toxicol; 1995 Oct; 19(6):519-21. PubMed ID: 8926749 [TBL] [Abstract][Full Text] [Related]
52. Evidence for prejunctionally located beta 2-adrenoceptors in the cat spleen. Dahlöf C; Hedberg A; Nerme V Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):362-7. PubMed ID: 3022158 [TBL] [Abstract][Full Text] [Related]
53. Different steric characteristics of beta 1- and beta 2-adrenoceptors. Morris TH; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(2):176-9. PubMed ID: 6092973 [TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics of metoprolol enantiomers following single and multiple administration of racemate in rat. Mostafavi SA; Foster RT Int J Pharm; 2000 Jul; 202(1-2):97-102. PubMed ID: 10915931 [TBL] [Abstract][Full Text] [Related]
55. Influence of lipophilicity and chirality on the selectivity of ligands for beta 1- and beta 2-adrenoceptors. el Tayar N; Testa B; van de Waterbeemd H; Carrupt PA; Kaumann AJ J Pharm Pharmacol; 1988 Sep; 40(9):609-12. PubMed ID: 2907026 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and evaluation of 1'-[18F]fluorometoprolol as a potential tracer for the visualization of beta-adrenoceptors with PET. de Groot TJ; van Waarde A; Elsinga PH; Visser GM; Brodde OE; Vaalburg W Nucl Med Biol; 1993 Jul; 20(5):637-42. PubMed ID: 8395276 [TBL] [Abstract][Full Text] [Related]
57. Regional distribution of myocardial beta-adrenoceptors in the cat. Lathers CM; Levin RM; Spivey WH Eur J Pharmacol; 1986 Oct; 130(1-2):111-7. PubMed ID: 3023110 [TBL] [Abstract][Full Text] [Related]
58. Pharmacologic characterization in vitro and in vivo of iodine 123-labeled derivatives of the beta-adrenoceptor antagonist CGP12177, designed for the imaging of cardiac beta-receptors. Dubois EA; Somsen GA; van den Bos JC; Janssen AG; Boer GJ; Batink HD; van Royen EA; Pfaffendorf M; van Zwieten PA J Nucl Cardiol; 1996; 3(3):242-52. PubMed ID: 8805744 [TBL] [Abstract][Full Text] [Related]
59. Receptor binding assays in analysing the bioavailability and pharmacodynamic bioequivalence of active drug moieties. A study of metoprolol. Kaila T; Roivas L; Neuvonen PJ Eur J Clin Pharmacol; 1994; 46(3):237-42. PubMed ID: 8070504 [TBL] [Abstract][Full Text] [Related]
60. Effects of benzylic hydroxyl substitution on the alpha-adrenoceptor blocking activity of tolazoline. Ruffolo RR; Nichols AJ; Patil PN; Hamada A; Clark M; Miller DD Eur J Pharmacol; 1988 Nov; 157(2-3):235-9. PubMed ID: 2906294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]